JIANGSU SINOPEP-ALLSINO BIOPHARMACEUTICAL financial statements, including revenue, expenses, profit, and loss
The total revenue of 688076 for the last quarter is 355.11 M CNY, and it's 10.40% higher compared to the previous quarter. The net income of Q1 24 is 66.33 M CNY.